Grosset, D. and Grosset, A. (2010) The movement disorder society - 14th international congress of Parkinson's disease and movement disorders. IDrugs, 13(8), 539--542. (PMID:20721824)
Full text not currently available from Enlighten.
Abstract
The 14th International Congress of Parkinson's Disease and Movement Disorders, held in Buenos Aires, included topics covering new therapeutic developments in the field of Parkinson's disease and other movement disorders. This conference report highlights selected presentations on drug treatments for movement disorders, including safinamide (Merck Serono SA), PYM-50028 (Phytopharm plc), droxidopa, pardoprunox (Abbott Laboratories); treatment considerations for dystonia; exploiting existing drugs for new indications; and using genetics to assess drug therapy responses.
Item Type: | Articles |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Grosset, Professor Donald |
Authors: | Grosset, D., and Grosset, A. |
College/School: | College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience |
Journal Name: | IDrugs |
Publisher: | Thomson Scientific |
ISSN: | 1369-7056 |
ISSN (Online): | 2040-3410 |
Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record